Verastem, Inc.
VSTMBiotechnology
$9.66−1.78%As of Oct 29vs prior close
- Market cap
- $1.2B
- P/E (TTM)
- –
- From 52W high
- −9.21%
- EPS (YE25)
- -$3.02
- Revenue (YE25)
- $30.9M
- Net margin
- -677.59%
- Dividend yield
- 0.00%
Nomior Score
37
Emerging BreakoutSpeculativeBottom 24% of the scored universe
Growth75
Quality31
Value—
Momentum36
Resilience23
Growth
+2.11%revenue a year over 7 fiscal years
YE18 $26.7MYE25 $30.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 82% of revenue, narrower by 1966 pts on a year.
Who owns it
2funds, 1 tracked portfolio